Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. It also focuses on researching small molecule oncology compounds with a biomarker-driven approach that targets genetic vulnerabilities in cancer cells to deliver new therapies for patients suffering from aggressive hematologic. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Calithera Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Calithera Biosciences Inc 52 week high is $0.4999 as of May 04, 2024.
What is the 52-week low for Calithera Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Calithera Biosciences Inc 52 week low is $0.01 as of May 04, 2024.
What is Calithera Biosciences Inc stock price today?
Calithera Biosciences Inc stock price today is $0.02.
What was Calithera Biosciences Inc stock price yesterday?
Calithera Biosciences Inc stock price yesterday was $0.02.
What is the 50-day moving average of Calithera Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Calithera Biosciences Inc 50-day moving average is $0.0241.